Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma: A Multicenter, Randomized Controlled Trial
ConclusionsCidan Capsule in combination with TACE can reduce the incidence of early recurrence in HCC patients at high-risk of recurrence after radical hepatectomy and may be an appropriate option in postoperative anti-recurrence treatment. (Registration No. NCT 02253511)
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
More News: Cancer & Oncology | Carcinoma | China Health | Hepatocellular Carcinoma | Internal Medicine | Liver Cancer | Pain | Study